129 related articles for article (PubMed ID: 12816901)
21. Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.
Abbaszadegan MR; Tavasoli A; Velayati A; Sima HR; Vosooghinia H; Farzadnia M; Asadzedeh H; Gholamin M; Dadkhah E; Aarabi A
World J Gastroenterol; 2007 Mar; 13(10):1528-33. PubMed ID: 17461444
[TBL] [Abstract][Full Text] [Related]
22. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
[TBL] [Abstract][Full Text] [Related]
23. Isolation of stool-derived mucus provides a high yield of colonocytes suitable for early detection of colorectal carcinoma.
White V; Scarpini C; Barbosa-Morais NL; Ikelle E; Carter S; Laskey RA; Miller R; Coleman N
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2006-13. PubMed ID: 19589912
[TBL] [Abstract][Full Text] [Related]
24. Detection of the mutated K-Ras biomarker in colorectal carcinoma.
Doolittle BR; Emanuel J; Tuttle C; Costa J
Exp Mol Pathol; 2001 Jun; 70(3):289-301. PubMed ID: 11418008
[TBL] [Abstract][Full Text] [Related]
25. [Advances in early diagnosis of colorectal cancer based on detection of RNAs in stool.].
Qi ZT; Deng LL; Huang H; Zhao JH; Zhou GH
Yi Chuan; 2010 Oct; 32(10):994-1002. PubMed ID: 20943486
[TBL] [Abstract][Full Text] [Related]
26. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
27. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
[TBL] [Abstract][Full Text] [Related]
28. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS
Oncology; 2019; 97(3):173-179. PubMed ID: 31216561
[TBL] [Abstract][Full Text] [Related]
29. A simplified, noninvasive stool DNA test for colorectal cancer detection.
Itzkowitz S; Brand R; Jandorf L; Durkee K; Millholland J; Rabeneck L; Schroy PC; Sontag S; Johnson D; Markowitz S; Paszat L; Berger BM
Am J Gastroenterol; 2008 Nov; 103(11):2862-70. PubMed ID: 18759824
[TBL] [Abstract][Full Text] [Related]
30. Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
Ahlquist DA; Sargent DJ; Loprinzi CL; Levin TR; Rex DK; Ahnen DJ; Knigge K; Lance MP; Burgart LJ; Hamilton SR; Allison JE; Lawson MJ; Devens ME; Harrington JJ; Hillman SL
Ann Intern Med; 2008 Oct; 149(7):441-50, W81. PubMed ID: 18838724
[TBL] [Abstract][Full Text] [Related]
31. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
[TBL] [Abstract][Full Text] [Related]
32. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.
Kanaoka S; Yoshida K; Miura N; Sugimura H; Kajimura M
Gastroenterology; 2004 Aug; 127(2):422-7. PubMed ID: 15300574
[TBL] [Abstract][Full Text] [Related]
33. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
[TBL] [Abstract][Full Text] [Related]
34. Reproducibility of a multitarget stool-based DNA assay for colorectal cancer detection.
Brand RE; Ross ME; Shuber AP
Am J Gastroenterol; 2004 Jul; 99(7):1338-41. PubMed ID: 15233675
[TBL] [Abstract][Full Text] [Related]
35. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
[TBL] [Abstract][Full Text] [Related]
36. Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers.
Wu CW; Cao X; Berger CK; Foote PH; Mahoney DW; Simonson JA; Anderson BW; Yab TC; Taylor WR; Boardman LA; Kisiel JB; Ahlquist DA
Dig Dis Sci; 2017 Aug; 62(8):1985-1994. PubMed ID: 28660489
[TBL] [Abstract][Full Text] [Related]
37. A Stool Multitarget mRNA Assay for the Detection of Colorectal Neoplasms.
Herring E; Kanaoka S; Tremblay E; Beaulieu JF
Methods Mol Biol; 2018; 1765():217-227. PubMed ID: 29589311
[TBL] [Abstract][Full Text] [Related]
38. [Fecal Biomarker for Colorectal Cancer Diagnosis].
Koga Y; Yamazaki N; Matsumura Y
Rinsho Byori; 2015 Mar; 63(3):361-8. PubMed ID: 26524859
[TBL] [Abstract][Full Text] [Related]
39. Early detection of colorectal cancer: from conventional methods to novel biomarkers.
Vatandoost N; Ghanbari J; Mojaver M; Avan A; Ghayour-Mobarhan M; Nedaeinia R; Salehi R
J Cancer Res Clin Oncol; 2016 Feb; 142(2):341-51. PubMed ID: 25687380
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
